Table 2 CDCA8 expression correlated with clinical pathological characteristics (logistic regression)
From: CDCA8 as an independent predictor for a poor prognosis in liver cancer
Clinical characteristics | Total (N) | Odds ratio in CDCA8 expression | P-value |
|---|---|---|---|
T stage (T1/2 vs. T3/4 ) | 415 | 1.64 (1.03–2.62) | 0.035 |
N stage (N0 vs. N1 ) | 298 | 3.11 (0.70-21.48) | 0.169 |
M stage (M0 vs. M1 ) | 311 | 0.74 (0.14–3.44) | 0.703 |
Clinical stage (I/II vs. III/IV) | 394 | 1.66 (1.04–2.67) | 0.034 |
Age (≤ 61 vs.> 61) | 376 | 1.30 (0.86–1.95) | 0.212 |
Gender (Female vs. Male) | 418 | 0.70 (0.47–1.06) | 0.095 |
Histologic grade (G1 vs.G4) | 68 | 6.71 (1.76–33.18) | 0.009 |
Histological type (CHOL vs. LIHC) | 418 | 0.24 (0.10–0.54) | 0.001 |
Race (Not white vs. White) | 408 | 0.88 (0.594–1.31) | 0.544 |